Bioleum Corporation Acquires RenFuel’s Intellectual Property Portfolio
VIRGINIA CITY, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE American: LODE, the "Company") today announced that one of its strategic investees, Bioleum Corporation ("Bioleum"), acquired substantially all of the patents and other intellectual property...
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX Supporting NDA Submission
NDA to be Submitted on a Rolling Basis, Beginning Early 2026PETACH TIKVA, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it...
TETRA TECHNOLOGIES, INC. AND MAGRATHEA METALS, INC. ADVANCE JOINT VENTURE PLANS TO PRODUCE MAGNESIUM IN ARKANSAS
Critical mineral extraction represents another key step in ONE TETRA 2030 strategy SPRING, Texas, Dec. 2, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced today that it has signed a term sheet outlining key parameters to...
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE WELLS FARGO 24TH ANNUAL ENERGY & POWER SYMPOSIUM
SPRING, Texas, Dec. 1, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, VP of Investor Relations and Treasurer, will be hosting one-on-one meetings with...
Jewett-Cameron Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results
Company to host webcast today, December 1, 2025, at 4:30 p.m. Eastern time NORTH PLAINS, Ore., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (the "Company"; Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces,...
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis" or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced...
Hotel101 Global Announces a Joint Venture with Definitive Binding Agreements Signed for the Development of Hotel101 in Milan, Italy
HOTEL101-MILAN IS SET TO HAVE APPROX. 429 ROOMS TO RISE IN A 1.4 HECTARE PRIME SITE AT SAN DONATO MILANESE, ABOUT A 7-MINUTE DRIVE TO THE MILAN LINATE AIRPORT HOTEL101-MILAN IS EXPECTED TO GENERATE EUR85.8 MILLION IN SALES REVENUE HOTEL101-MILAN IS SET TO BECOME THE...
Zoomd Technologies Reports Third Quarter 2025 Financial Results
Conference call will be held on November 28, 2025 at 11 AM ET TORONTO, Nov. 28, 2025 /PRNewswire/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site infections and the therapeutic potential of D-PLEX PETACH TIKVA, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd....
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
DENVER, CO / ACCESS Newswire / November 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...
Comstock Metals Receives Notification of Eligibility For Final Permit
Air Quality Permit For Its First-Of-A-Kind, Industrial Scale Solar Panel Processing FacilityVIRGINIA CITY, Nev., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") and Comstock Metals LLC ("Comstock Metals"), a leader in the...
Zoomd Technologies Reschedules Release of Report Third Quarter 2025 Financial Results
Conference call will be held on November 28, 2025 at 11 AM ET TORONTO, Nov. 21, 2025 /PRNewswire/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
Jitri LiqTech Breaks Ground on Marine-focused R&D Test Center and Localization Facility in China and Completes Regional Spare Parts Warehouse
BALLERUP, Denmark, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Jitri LiqTech, the China based joint venture of LiqTech International, Inc. (NASDAQ: LIQT), has broken ground on a new marine-focused R&D test center and localization facility in Haimen, Nantong. The company...
Zoomd Technologies to Report Third Quarter 2025 Financial Results
Conference call will be held on November 27, 2025 at 11 AM ET TORONTO, Nov. 20, 2025 /PRNewswire/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID’s New AI-Powered Feature
TORBAL DIVISION SALES UP 15% YTDLAUNCH OF VIVID'S FIRST AI-POWERED FEATURESECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26 Investor Call to be held Thursday, November 20th at 11:00 a.m. Eastern Time BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Scientific...
Altigen Technologies and Intelligent Protection Management Corp. Announce Go-To-Market Collaboration to Accelerate Growth, Reduce IT Complexity, and Expand Recurring Revenue Opportunities
NEWARK, NEW JERSEY / ACCESS Newswire / November 19, 2025 / Altigen Technologies ("Altigen") (OTCQB:ATGN), a Microsoft Cloud Solutions provider delivering integrated Teams voice, AI-powered engagement, and analytics platforms and Intelligent Protection Management Corp....
Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025
Investor Call to be held at 11:00 AM Eastern TimeBOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will file the Form 10Q...
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology...
Comstock Inc. to Participate in Water Tower Research Fireside Chat on Tuesday, November 18, 2025
VIRGINIA CITY, Nev., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE American: LODE) ("Comstock" and the "Company") today announced that Corrado De Gasperis, Executive Chairman and CEO of Comstock Inc. and its subsidiaries, Comstock Metals, LLC and Comstock...
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump- Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA / ACCESS Newswire / November 14, 2025 / Modular Medical, Inc....
Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
Conference Call Scheduled for today, November 13, 2025, at 5:00pm ETGARDNER, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and...
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance at September 30, 2025Company remains on track to launch EXXUA™...
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
- Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European patent granted covering use of brilaroxazine for the treatment of...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and...
LiqTech International Announces Third Quarter 2025 Financial Results
BALLERUP, Denmark, Nov. 13, 2025 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (Nasdaq: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the third...
